Suchergebnisse - "Challener, Douglas W"

PubPharm (2)

1

Curbing the Delta Surge : Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019

enthalten in: Mayo Clinic proceedings | 2022

von Razonable, R. | O'Horo, J. | Challener, D. | +13

2

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019

enthalten in: Mayo Clinic proceedings | 2022

von O'Horo, J. | Challener, D. | Anderson, R. | +8

1
[1]